aTYR PHARMA (ATYR) Shares Outstanding (2014 - 2026)
aTYR PHARMA's Shares Outstanding came in at 98.07 million for Q2 2026, up 8.8% from 90.12 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Shares Outstanding (2014 - 2026) Analysis & Trends
For FY2025, aTYR PHARMA's Shares Outstanding was 92.99 million, up 25.2% from FY2024.
- Shares Outstanding has increased in each of the last ten years, with a five-year compound annual growth rate of 59.0% (FY2020 to FY2025).
- Going back by year, Shares Outstanding was 74.26 million in FY2024 (+38.5%), 53.61 million in FY2023 (+88.6%), 28.42 million in FY2022 (+48.9%) and 19.08 million in FY2021 (+108.3%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q1 2014.
- Year-over-year, Shares Outstanding has increased for 41 consecutive quarters, with growth averaging 25.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding ranged from 8.8% (Q2 2026) to 108.3% (Q4 2021).
- Business Quant data shows ATYR's Shares Outstanding at 98.04 million (Q1 2026), 92.99 million (Q4 2025) and 97.15 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | aTYR PHARMA | 16.81 Mn | -276.01 Mn | - | 98.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.07 Mn |
| Mar 31, 2026 | 98.04 Mn |
| Dec 31, 2025 | 92.99 Mn |
| Sep 30, 2025 | 97.15 Mn |
| Jun 30, 2025 | 90.12 Mn |
| Mar 31, 2025 | 86.49 Mn |
| Dec 31, 2024 | 74.26 Mn |
| Sep 30, 2024 | 75.80 Mn |
| Jun 30, 2024 | 72.28 Mn |
| Mar 31, 2024 | 66.08 Mn |
| Dec 31, 2023 | 53.61 Mn |
| Sep 30, 2023 | 57.89 Mn |
| Jun 30, 2023 | 55.14 Mn |
| Mar 31, 2023 | 41.90 Mn |
| Dec 31, 2022 | 28.42 Mn |
| Sep 30, 2022 | 28.66 Mn |
| Jun 30, 2022 | 28.06 Mn |
| Mar 31, 2022 | 27.82 Mn |
| Dec 31, 2021 | 19.08 Mn |
| Sep 30, 2021 | 18.16 Mn |
API Access
aTYR PHARMA Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();